323 related articles for article (PubMed ID: 20933557)
1. Molecular imaging with SPECT as a tool for drug development.
Gomes CM; Abrunhosa AJ; Ramos P; Pauwels EK
Adv Drug Deliv Rev; 2011 Jun; 63(7):547-54. PubMed ID: 20933557
[TBL] [Abstract][Full Text] [Related]
2. Microdosing studies using accelerated mass spectrometry as exploratory investigational new drug trials.
Bae SK; Shon JH
Arch Pharm Res; 2011 Nov; 34(11):1789-98. PubMed ID: 22139681
[TBL] [Abstract][Full Text] [Related]
3. Impact of microdosing clinical study -- why necessary and how useful?
Sugiyama Y; Yamashita S
Adv Drug Deliv Rev; 2011 Jun; 63(7):494-502. PubMed ID: 20950660
[TBL] [Abstract][Full Text] [Related]
4. PhRMA survey on the conduct of first-in-human clinical trials under exploratory investigational new drug applications.
Karara AH; Edeki T; McLeod J; Tonelli AP; Wagner JA
J Clin Pharmacol; 2010 Apr; 50(4):380-91. PubMed ID: 20097935
[TBL] [Abstract][Full Text] [Related]
5. [Molecular imaging in evaluation of in vivo behavior of drugs].
Saji H
Nihon Rinsho; 2007 Feb; 65(2):363-9. PubMed ID: 17302285
[TBL] [Abstract][Full Text] [Related]
6. Using imaging biomarkers to accelerate drug development and clinical trials.
Pien HH; Fischman AJ; Thrall JH; Sorensen AG
Drug Discov Today; 2005 Feb; 10(4):259-66. PubMed ID: 15708744
[TBL] [Abstract][Full Text] [Related]
7. Leveraging exploratory investigational new drug studies to accelerate drug development.
Jacobson-Kram D; Mills G
Clin Cancer Res; 2008 Jun; 14(12):3670-4. PubMed ID: 18559581
[TBL] [Abstract][Full Text] [Related]
8. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography for use in microdosing studies.
Wagner CC; Müller M; Lappin G; Langer O
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and first in vivo evaluation of new selective high affinity beta1-adrenoceptor radioligands for SPECT based on ICI 89,406.
Wagner S; Kopka K; Law MP; Riemann B; Pike VW; Schober O; Schäfers M
Bioorg Med Chem; 2004 Aug; 12(15):4117-32. PubMed ID: 15246089
[TBL] [Abstract][Full Text] [Related]
11. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
12. Comparative requirements for exploratory clinical trials -- eIND, eCTA and microdosing.
Muller PY
Adv Drug Deliv Rev; 2011 Jun; 63(7):511-7. PubMed ID: 21034787
[TBL] [Abstract][Full Text] [Related]
13. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
Harapanhalli RS
Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
[TBL] [Abstract][Full Text] [Related]
14. The use of imaging in preclinical drug development.
Vanderheyden JL
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):374-81. PubMed ID: 19834446
[TBL] [Abstract][Full Text] [Related]
15. Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature.
Narendran R; Martinez D
Synapse; 2008 Nov; 62(11):851-69. PubMed ID: 18720516
[TBL] [Abstract][Full Text] [Related]
16. Interpretation of treatment results with biological agents: is there a need for a new methodology?
Begent RH
J BUON; 2007 Sep; 12 Suppl 1():S53-8. PubMed ID: 17935278
[TBL] [Abstract][Full Text] [Related]
17. Mass effect of injected dose in small rodent imaging by SPECT and PET.
Kung MP; Kung HF
Nucl Med Biol; 2005 Oct; 32(7):673-8. PubMed ID: 16243641
[TBL] [Abstract][Full Text] [Related]
18. [Molecular imaging with positron emission tomography and single photon emission computer tomography. Status and perspectives].
Kjaer A
Ugeskr Laeger; 2005 Nov; 167(48):4549-52. PubMed ID: 16324434
[TBL] [Abstract][Full Text] [Related]
19. Big physics, small doses: the use of AMS and PET in human microdosing of development drugs.
Lappin G; Garner RC
Nat Rev Drug Discov; 2003 Mar; 2(3):233-40. PubMed ID: 12612650
[TBL] [Abstract][Full Text] [Related]
20. The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology.
Malizia AL
J Psychopharmacol; 2006 Jul; 20(4 Suppl):100-7. PubMed ID: 16785278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]